3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Prostatic Neoplasms
6
Neuroendocrine Tumors
5
Neoplasms
4
Breast Neoplasms
4
Esophageal Neoplasms
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Smoking Cessation
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Multiple Pulmonary Nodules
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, T-Cell
1
Lymphoma, B-Cell
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Large B-cell Lymphoma
1
Hypoxia
1
Hodgkin Disease
1
Hepatic Malignancies
1
Interventions
Cytarabine
272
Cyclophosphamide
136
fludarabine phosphate
127
Azacitidine
117
Peripheral Blood Stem Cell Transplantation
95
Busulfan
93
Filgrastim
80
fludarabine
78
Mycophenolic Acid
78
Decitabine
78
Idarubicin
76
Etoposide
76
Whole-Body Irradiation
75
Daunorubicin
72
Tacrolimus
71
Cyclosporine
64
Methotrexate
62
Mitoxantrone
57
Clofarabine
55
Antilymphocyte Serum
55
Granulocyte Colony-Stimulating Factor
51
Gemtuzumab
50
Melphalan
49
venetoclax
47
Radiotherapy
30
sargramostim
28
Bortezomib
25
thymoglobulin
24
aldesleukin
24
Injections
24
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Leukemia, Myeloid, Acute
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT03429387
2022-05-17
PIPPIN
Peter MacCallum Cancer Centre, Australia
Phase NA
Completed
147 enrolled